RBC Capital Maintains Outperform on HealthEquity, Lowers Price Target to $100

Benzinga Newsdesk www.benzinga.com Negative 95.0%

Neg 95% Neu 0% Pos 0%

RBC Capital analyst Daniel R. Perlin maintains HealthEquity (NASDAQ:HQY) with a Outperform and lowers the price target from $110 to $100.